Statistics for Atossa Genetics (id:5659 ATOS)

Valuation metrics

Market cap

161.03M

Enterprise value

86.26M

Trailing P/E (ttm)

-5.08

Forward P/E

-4.74

PEG ratio

-4.74

Price/Sales (ttm)

Price/Book (mrq)

2.18

Enterprise Value/Revenue

Enterprise Value/EBITDA

-2.93

Overview

Shares outstanding

125.80M

Float

117.96M

Shares short

12.77M

% Held by insiders

0.00%

% Held by institutions

0.28%

Average volume (10 days)

897.49K

Average volume (90 days)

Price summary

52-Week low

0.70

52-Week high

2.31

52-Week change

35.25%

Beta

1.23

50-Day moving average

1.44

200-Day moving average

1.37

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

April 20th, 2018

Ex-dividend date

Last split factor

2:1

Last split date

April 20th, 2018

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-20.35%

Return on equity

-31.30%

Income statement

Revenue (ttm)

Revenue per share (ttm)

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-29,462,000.00

Net income to common (ttm)

-26,911,000.00

Diluted EPS (ttm)

-0.21

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

74.77M

Total cash per share (mrq)

0.59

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

1.33K%

Book value per share (mrq)

0.59

Cash flow

Cash flow statement

-19,550,000.00

Levered free cash flow (LFCF)

-12,761,625.00